Clinical Trial: A Phase 2/3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy

U.S., July 24 -- ClinicalTrials.gov registry received information related to the study (NCT07723963) titled 'A Phase 2/3, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy' on July 20.

Brief Summary: This study is being conducted to evaluate the safety and efficacy of JZP926 capsule in participants with Juvenile Myoclonic Epilepsy (JME).

Study Start Date: Sept. 01

Study Type: INTERVENTIONAL

Condition: Juvenile Myoclonic Epilepsy

Intervention: DRUG: JZP926 capsule

Oral administration BID according to body weight

DRUG: Placebo

Oral administration BID according to body weight

Recruitment Status: NOT_YET_RECRUITING

Sp...